A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

NCT00001108 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Ritonavir
DRUG: Nelfinavir mesylate
DRUG: Saquinavir
DRUG: Nevirapine
DRUG: Lamivudine
DRUG: Stavudine
DRUG: Didanosine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]